ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag infrastructure immunology culture ecology

Researchers Learn from Plant Viruses to Protect Crops
Claire Asher | Feb 1, 2018 | 10+ min read
Plants are locked in an ancient arms race with hostile viruses, but genome editing is giving crops the upper hand.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
BIOTEC
BIOTEC | Jan 12, 2010 | 5 min read
color = "#DF1F26";.pullquote_left1, .pullquote_right1, .pullquote_left, .pullquote_right { color: #FEF8F6; background: #939598 }.breakhead { color: #DF1F26; border-bottom: 1px solid #DF1F26; } BIOTEC Excellence in Science, Relevance to National Agenda Established in 1983, BIOTEC is one of four centers under the umbrella of the National Science and Technology Development Agency (NSTDA), an autonomous government body. The Center serves as a
From Me to We
Richard Gallagher | Jun 1, 2008 | 3 min read
The Scientist Community is about to take off. We hope you'll join us.
African Sleeping Sickness: A Recurring Epidemic
Ricki Lewis | May 12, 2002 | 5 min read
African trypanosomiasis is making an unwelcome comeback. But unlike other returning diseases, this one has a drug treatment—eflornithine—that disappeared from the market when it failed to cure cancer. Yet like Viagra's origin from a curious side effect in a clinical trial, so too was eflornithine reborn. "When it was discovered that it removes mustaches in women, it suddenly had a market: western women with mustaches," says Morten Rostrup, president of the international council for M
Vaccines: Victims of Their Own Success?
Ricki Lewis | Jul 18, 2004 | 10+ min read
Perhaps in no area is the divide between the developed and developing worlds as striking as it is for vaccines: While healthcare consumers in economically advantaged nations worry about risk, in developing nations compelling need forces a focus on potential benefit. "People in the United States want a quick solution, not prevention, so they prefer drugs to vaccines. Elsewhere, people are afraid of drugs and side effects, and prefer vaccines," says Shan Lu, a primary-care physician who has worked
Biochemical, Reagents Kits Offer Scientists Good Return On Investment
Holly Ahern | Jul 23, 1995 | 8 min read
Investment Author:Holly Ahern If you were to ask several life scientists to name a particular biochemical product that they simply could not do without, you'd probably get a myriad of answers that would mirror the research interests of the group you questioned. A molecular evolutionist trying to differentiate two closely related species of monkeys by restriction fragment-length polymorphism (RFLP) analysis might cite restriction enzymes, which can cut DNA into pieces of varying length. A cell b
Articles Alert
Simon Silver | Jul 8, 1990 | 7 min read
The Scientist has asked a group of experts to comment periodically upon recent articles that they have found noteworthy. Their selections, presented herein every issue, are neither endorsements of content nor the result of systematic searching. Rather, the list represents personal choices of articles the columnists believe the scientific community as a whole may also find interesting. Reprints of any articles cited here may be ordered through The Genuine Article, 3501 Market St., Philadelphia,

Run a Search

ADVERTISEMENT